PP_1170x120_10-25-21

FreeStyle Libre system (FreeStyle LibreLinkii mobile app and LibreViewiii cloud-based system)

Abbott and Novo Nordisk to provide integrated digital solution to people with diabetes using insulin

Abbott and Novo Nordisk  to provide integrated digital solution to people with diabetes using insulin

ABBOTT PARK, Ill. —Abbott and Novo Nordisk announced Wednesday a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk pre-filled and durable connected pens directly into the digital health tools compatible with the FreeStyle Libre system (FreeStyle LibreLinkii mobile app and LibreViewiii cloud-based system). The partnership reflects both companies′ commitment to make diabetes